ArticleNeurologia medico-chirurgica2025
Multifactorial Biomarkers for "Talk and Deteriorate" after Head Trauma Identified Using Machine Learning.
Article in Neurologia medico-chirurgica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Talk and Deteriorate refers to a clinical course where a patient is able to speak immediately after a traumatic brain injury but subsequently deteriorates in consciousness. Talk and Deteriorate outcomes are poor, and reliable prediction may help improve them. We searched for multifactorial biomarkers-combinations of multiple risk factors-assuming they would predict Talk and Deteriorate more reliably than single factors. A total of 680 consecutive patients aged ≥16 years with intracranial traumatic lesions and a Glasgow Coma Scale of 13-15 upon admission were included. Information on 27 factors at admission and whether Talk and Deteriorate developed was collected. The correlation between Talk and Deteriorate incidence and each factor was evaluated using univariate analysis. Multifactorial biomarkers associated with a high Talk and Deteriorate incidence were identified using a brute force method combined with clustering based on combinations of factors and various thresholds for each. Among the 680 patients, 89 (13.1%) developed Talk and Deteriorate. A total of 94 multifactorial biomarkers with a Talk and Deteriorate incidence rate of ≥50.0% were identified. These multifactorial biomarkers, which included factors previously suspected to be related to Talk and Deteriorate, were associated with a higher Talk and Deteriorate incidence than each factor alone. Thus, this study indicates that predicting Talk and Deteriorate is more reliable when based on multifactorial biomarkers than on single factors. Factors not previously reported as independent biomarkers contributed as components of multifactorial biomarkers, while previously reported factors played more important roles within them. Thus, this study revealed multifactorial contributions of factors related to Talk and Deteriorate. Future studies focusing on these biomarkers, incorporating pathophysiologic insights, will improve Talk and Deteriorate outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.